⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

Official Title: Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

Study ID: NCT04882475

Interventions

Study Description

Brief Summary: Retrospective observational study with a prospective biological evaluation of an historical cohort of first relapsed-refractory patients with mantle cell lymphoma who were relapsed or refractory to rituximab and chemotherapy containing induction regimens with curative intent.

Detailed Description: Biological samples from 80 Mantle Cell Lymphoma (MCL) patients will be collected and analyzed in 30 Italian sites in 36 months. Patients will be identified and selected both on a clinical base and according to the availability of Formaline-fixed paraffin-embedded (FFPE) material, frozen material or viable cryopreserved cells at Mantle Cell Lymphoma (MCL) diagnosis. They will be analyzed in 4 subgroups, each with different clinical specificity: 1) refractory to Induction Chemoimmunotherapy (CIT); 2) refractory to Bruton Tyrosine kinase (BTK) inhibitors (BTKi); 3) sensitive to induction Induction Chemoimmunotherapy (CIT); 4) sensitive to BTK inhibitors (BTKi). Each group will undergo central pathology revision with other immunohistochemical studies (Verona, Dr. Parisi; Milano, Prof. Ponzoni; Vicenza, Dr. D'Amore; Brescia, Prof. Facchetti). Formaline-fixed paraffin-embedded (FFPE) diagnostic specimens of Mantle Cell Lymphoma (MCL) will be screened by immunohistochemistry for the expression of immunoglobulin (Ig) heavy chains to identify Mantle Cell Lymphoma (MCL) cases lacking Immunoglobulin (Ig) expression. Cytofluorimetric and molecular studies will be performed in the laboratories of the Verona University and at IFOM (Istituto FIRC di Oncologia Molecolare (FIRC = Fondazione Italiana per la Ricerca sul Cancro)). Specific methods will be used: Flow cytometry for the status of surface Ig expression and multiplexed phospho-specific flow cytometry, NGS (Next Generation Sequencing), Immunoglobulin (IgH/IgL V(D)J) profiling by BIOMED2 protocol-based, NGS (Next Generation Sequencing) technology in the relapsed-refractory mantle cell lymphoma (R/R MCL) cases, Chromatin accessibility studies by Assay for Transposase-Accessible Chromatin sequencing (ATAC-seq) (on viable cell suspensions or frozen pellets) and Gene Expression Profiling (GEP) by RNA-sequencing and RNA studies of the MALT1-MYC ((Mucosa-associated lymphoid tissue lymphoma translocation protein 1 - MYC) pathway.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy

P.O. Spirito Santo di Pescara - UOS Dipartimentale - Centro di diagnosi e Terapia dei linfomi, Pescara, PE, Italy

AOU Senese - U.O.C. Ematologia, Siena, SI, Italy

A.O. SS. Antonio e Biagio e Cesare Arrigo, SC Ematologia, Alessandria, , Italy

AOU Ospedali Riuniti - Clinica di Ematologia, Ancona, , Italy

Centro Riferimento Oncologico - S.O.C. Oncologia Medica A, Aviano, , Italy

AOU Policlinico Consorziale - U.O. Ematologia con Trapianto, Bari, , Italy

IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, , Italy

ASST Spedali Civili di Brescia - Ematologia, Brescia, , Italy

A.O. S. Croce e Carle, Cuneo, , Italy

Azienda Ospedaliera Universitaria Careggi- Unità funzionale di ematologia, Firenze, , Italy

Ospedale Vito Fazzi - Ematologia, Lecce, , Italy

Istituto Scientifico San Raffaele - Unità Linfomi - Dipartimento Oncoematologia, Milano, , Italy

Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda - Ematologia, Milano, , Italy

AOU Maggiore della Carità di Novara - SCDU Ematologia, Novara, , Italy

AOU di Padova - Ematologia, Padova, , Italy

IRCCS Policlinico S. Matteo di Pavia - Div. di Ematologia, Pavia, , Italy

Ospedale Guglielmo da Saliceto - U.O.Ematologia, Piacenza, , Italy

Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia - Ematologia, Reggio Emilia, , Italy

Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, , Italy

Policlinico Umberto I - Universitа "La Sapienza" - Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione, Roma, , Italy

Universitа Cattolica S. Cuore - Ematologia, Roma, , Italy

A.O.U. Citta della Salute e della Scienza di Torino - S.C.Ematologia, Torino, , Italy

A.O.U. Citta della Salute e della Scienza di Torino- Ematologia Universitaria, Torino, , Italy

Ospedale S. Chiara - S.S. di Ematologia, Trento, , Italy

Ospedale Ca' Foncello - S.C di Ematologia, Treviso, , Italy

Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia, Trieste, , Italy

Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - SOC Clinica Ematologica, Udine, , Italy

Ospedale di Circolo - U.O.C Ematologia, Varese, , Italy

AOU Integrata di Verona - U.O. Ematologia, Verona, , Italy

ULSS 8 Berica - Ospedale S. Bortolo - Ematologia, Vicenza, , Italy

Contact Details

Name: Francesca Maria Quaglia

Affiliation: Azienda Ospedaliera Universitaria (AOU) Integrata di Verona - Unità Operativa di Ematologia

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: